METRIX PARTNERS
For growing tech companies that need to build a first-in-class finance operation, Metrix Partners provides part-time CFO and financial advisory services, straight from the best peer companies and with a flexible cost arrangement.
WHY A CFO?
“A solid operating CFO is a blessing to an early stage CEO”. We concur with Firas Raouf from Openview Partners. When is the right time to hire a part-time CFO? How much does it cost?
NEWS FEED
Cledara raises a $3.4m Seed round advised by Metrix Partners
Cledara, the leading all-in-one SaaS purchase and management platform, has raised $3.4M led by Nauta Capital, with participation from existing investors Anthemis. Metrix Partners has advised this transaction. Read the full news here
Northern Biologics Announces Global Acquisition of Clinical-Stage Antibody MSC-1 by AstraZeneca
Northern Biologics has reached an agreement for the acquisition of the company’s lead asset, MSC-1, by an AstraZeneca subsidiary. MSC-1 is an anti-LIF antibody that has completed Phase 1a clinical studies for the treatment of solid tumors. Deal terms are undisclosed. Metrix Partners has been collaborating with Mosaic Biomedicals, an affiliate of Northern Biologics, since […]
Our new clients during Q3
Amidst the chaos and the economic downturn created by Covid-19, the best startups continue to choose Metrix Partners as their externalized finance function. This both permanently and on a project basis. During Q3 2020, just closed, we are very happy to announce that Netrivals (SaaS), Methinks (Healthcare), Deepull (Heathcare), OrbitalAds (Adtech) and Green Eagle Solutions […]
Metrix Advises Nauta Capital in their investment of €4.7M in HappySignals.
Helsinki, Finland (September 17th, 2020) Helsinki-based HappySignals, an Employee Experience Management Platform provider, has announced the successful closure of a €4.7M series A funding round led by Nauta Capital with Vendep Capital also in participation. HappySignals will further its mission of helping enterprise IT leaders identify what needs to change so they can build happy, […]
Bringing Apps Together: Our client Onna Raises $27M Series B For Knowledge Integration Platform
Onna announced a $27 million Series B investment on Wednesday led by Atomico, with participation from Glynn Capital. Previous investors Dawn Capital, Nauta Capital and Slack Fund invested in this latest round as well. Since forming in 2016, the company has raised a total of $43 million, which includes an $11 million Series A round in June 2019, Griswold said. The company, based in […]
OUR CLIENT ONA THERAPEUTICS RAISES €30M IN SERIES A FINANCING
Ona Therapeutics, which is focused on the discovery and development of therapeutic biologics to treat metastatic cancer, announced today the closing of a €30 million Series A financing, with participation from existing investor Asabys Partners and new investors Alta Life Sciences, Bpifrance – InnoBio 2, Fund+ and Ysios Capital. You can read the full press […]
Alta Life Sciences and CDTI invest €7.6M in Accure Therapeutics
Alta Life Sciences and CDTI invest €7.6M in Accure Therapeutics, a new company that will develop a portfolio of new medicines to address CNS diseases. Accure Therapeutics, a new pharma R&D player in the Central Nervous System (CNS) field, announces today its launch with a Series A round of funding totalling €7.6 million ($8.1M). The […]
Boehringer Ingelheim Acquires Northern Biologics’ Preclinical Cancer Antibody Pipeline, Expanding Immuno-oncology Portfolio
Boehringer Ingelheim today announced the acquisition of Northern Biologics Inc. By acquiring this entity, which focuses on therapeutic antibodies targeting the tumor microenvironment, Boehringer Ingelheim is now positioned at the forefront of the stromal biology space – an emerging area in cancer immunology. The seller will retain the Northern Biologics name and will continue to […]
New clients!
It is always a pleasure seeing how new clients choose Metrix Partners to help them manage finance in a strategic way, and with best practices straight from the best peers in SaaS, healthcare, DTC and other business models. The last few months have been specially active and we are proud to welcome Tropicfeel, Woffu, Quality […]
Metrix Partners advises Cambridge-based AI startup techspert.io in their GBP 3.7M Series A round led by Nauta Capital
techspert.io, the first AI-driven technology for mapping the world‘s expertise and connecting businesses directly to the source of technical and market insights, has raised £3.76 million Series A funding. Founded in 2016, techspert.io eliminates the limitations of human-led market research with AI–driven science. Deep search technology uses reinforcement learning models to autonomously crawl online content and data, mapping expertise in real-time and precisely matching specialists to business […]
Facebook acquires our client, the Spanish cloud video gaming company PlayGiga
Facebook acquires Spanish cloud video gaming company PlayGiga. A Facebook spokesperson confirmed the deal to CNBC, after Spanish business newspaper Cinco Dias reported that the acquisition was coming. Read the Techcrunch article here.
Metrix Partners advises Barcelona-based edtech startup World Mastery €3M Series A round led by Nauta Capital
World Mastery, a content-as-a-service platform which provides structured online courses, has secured a €3M Series A round led by Pan-European VC Nauta Capital. The edtech company serves the non-academic learning needs of businesses and professionals by providing access to highly-curated specialist courses delivered by maestros – renowned experts – in subjects including tennis, basketball, dance, yoga, fitness, cooking and hairstyle. Read the full story here
Onna Technologies closes an $11 million series A led by Dawn Capital with participation from Dropbox and the Slack Fund
Our client Onna Technologies raised a massive $11 m series A round with participation by Nauta Capital, Dawn Capital and the corporate VC arms of Dropbox and Slack. More information here
Keyfactor acquires our client, the Spanish digital identity firm Redtrust
This is undoubtedly one of the highest profile transactions in the Spanish startup ecosystem this year. Keyfactor is invested by Insight Partners, and the purchase of Redtrust creates a very nice combination in a space that is red hot… digital certificates are and will be EVERYWHERE. Read more about the Keyfactor acquisition here
Psious closes a EUR 8m round and joins Metrix client list
We welcome Psious to our client list. This Barcelona-based VR startup has recently raised EUR 8m in a round led, among others, by Asabys, CCR abd Sabadell VC. Read the full article here
Biotech startup Ona Therapeutics raises EUR 1.5m from Sabadell Asabys and joins our client list
Biotech startup Ona Therapeutics raises EUR1.5m from Sabadell Asabys and joins our client list. Ona Therapeutics develops novel drugs for the treatment of metastatic cancer. Read the full article here.
Metrix Partners advises Nauta Capital on its $6m investment in Zenloop
zenloop, a German customer experience management platform, has raised $6M investment led by Pan-European VC, Nauta Capital with Piton Capital also joining the round. The investment will be used for internationalisation with a focus on expansion across Europe in 2019 in addition to doubling zenloop’s team size within the year. Read the full article here
Metrix Partners advises AXA Venture Partners in its €15m Series B round in Zenjob
Zenjob, the Berlin-based tech startup, has raised 15 million euros in the Series B financing round, led by AXA Venture Partners. Additional capital investors are the current investors Acton Capital Partners, Redalpine, and Atlantic Labs. Zenjob helps large and medium-sized businesses find on-demand student staff with just a few clicks. The capital will be invested […]
AELIX Therapeutics and Gilead Sciences Enter into a Clinical Research Collaboration Agreement
AELIX Therapeutics and Gilead Sciences Enter into a Clinical Research Collaboration Agreement to Evaluate a Therapeutic Vaccine and TLR7 Agonist Regimen for HIV Cure. AELIX Therapeutics will investigate the safety, immunogenicity, and efficacy of AELIX Therapeutics’ HTI vaccine and Gilead´s Toll-Like Receptor 7 agonist vesatolimod (GS-9620) in HIV-infected individuals. Read the full press release here
Our client Northern Biologics Enters the Clinic with its lead immuno-oncology antibody, MSC-1
Northern Biologics Inc., a developer of first-in-class immuno-oncology products, today announced that its lead immuno-oncology antibody, MSC-1, began clinical testing at Memorial Sloan Kettering Cancer Center with plans to soon expand to other world-leading sites in Canada and Europe. MSC-1 is a humanized antibody against a soluble cytokine called LIF (see “About LIF” below). LIF […]